Red light laser therapy is an optional adjunct that may reduce neuropathic pain for some people, especially those with diabetic peripheral neuropathy, but it is not proven to repair damaged nerves or reverse numbness. A 2023 systematic review of eight studies reported possible benefits, but the evidence remains limited and inconsistent.
The medical terms for this treatment include photobiomodulation therapy (PBM), low-level laser therapy (LLLT) and low-level light therapy.
Red Light Therapy for Neuropathy at a Glance
| Question | Evidence-based answer |
|---|---|
| Can it reduce nerve pain? | Possibly. Some small clinical trials and reviews report short-term improvements. |
| Can it restore damaged nerves? | Not established. Evidence for nerve regeneration in humans remains limited. |
| Is the evidence strongest for diabetic neuropathy? | Yes, although studies use different treatment protocols and have produced inconsistent results. |
| Is a home red-light panel equivalent to a medical laser? | No. Wavelength, power, dose, treatment time and treatment area vary between devices. |
| Should it replace medication or diabetes management? | No. It should only be considered an adjunctive treatment. |
| Is every red-light device FDA-cleared for neuropathy? | No. FDA authorization applies to particular devices and indications, not to all red-light products. |
What Does the Research Show?
The research shows possible symptom relief, but it does not yet establish that red light therapy repairs nerves or provides lasting control of neuropathy.
A 2023 systematic review of eight studies involving photobiomodulation for diabetic peripheral neuropathy reported improvements in neuropathic pain and nerve conduction. The review included both randomized and nonrandomized studies. The studies also used different wavelengths, doses and treatment schedules, which makes the results difficult to apply to every patient.
A 2025 systematic review of randomized trials involving peripheral nerve injuries and related conditions found a trend toward better pain, strength and sensation outcomes. Many of the included studies involved carpal tunnel syndrome or other focal nerve injuries rather than generalized neuropathy. The authors noted small samples, short follow-up periods and major differences in device settings.
A newer randomized pilot trial in diabetic peripheral neuropathy included 26 participants and tested 12 treatment sessions. The trial focused mainly on feasibility and early changes, so it cannot show whether red light therapy provides durable nerve repair or long-term symptom control.
Taken together, the evidence supports possible pain relief more strongly than it supports reversing the underlying nerve damage.
Why Might Red Light Laser Therapy Help?
Red light laser therapy may affect cellular energy signaling, inflammation and local circulation. Photobiomodulation delivers low-power red or near-infrared light to tissue, and these effects provide a possible biological explanation for symptom changes. They do not prove that the treatment regenerates nerves or improves long-term function.
The treatment is nonthermal, so properly used devices are not intended to heat or destroy tissue. Results depend on the device's wavelength, irradiance, energy dose, distance from the skin, treatment time and application technique.
Which Types of Neuropathy May Respond?
Evidence differs by condition. Diabetic peripheral neuropathy has the most direct research, while evidence for other forms of neuropathy is less developed.
Diabetic Peripheral Neuropathy
Some studies report lower foot pain, better sensory testing or improved nerve conduction after PBM or LLLT.
In the United States, FDA documentation for the prescription Erchonia DPN Laser describes red and violet laser treatment as an adjunctive prescription home treatment for temporary relief of diabetic peripheral neuropathy foot pain. The supporting study included 64 participants and measured pain relief after a three-week treatment period. This indication covers temporary pain relief, not nerve regeneration or a cure for diabetic neuropathy.
The FDA documentation applies to that device and its protocol. It does not mean that a generic red-light panel, laser wand or wellness device has the same evidence.
Chemotherapy-Induced Peripheral Neuropathy
Evidence for chemotherapy-induced peripheral neuropathy is less established. Photobiomodulation has been studied among several noninvasive treatments, but the research remains early. It should not replace an oncology treatment plan.
Carpal Tunnel Syndrome and Focal Nerve Compression
Some trials have examined photobiomodulation for carpal tunnel syndrome and other focal nerve problems. A 2025 review found a possible benefit for pain and sensory outcomes, but the treatment protocols varied considerably.
A compressed nerve still needs proper assessment. Depending on the cause and severity, splinting, activity modification, physical therapy, injections or surgery may be more suitable.
Unexplained Numbness or Tingling
Red light therapy should not be the first step when the cause of neuropathy is unknown. Peripheral neuropathy can result from diabetes, vitamin deficiencies, medication or toxin exposure, autoimmune disease, infection, trauma and nerve compression. Treating the cause may help prevent further nerve damage.
How Does It Compare With Established Neuropathy Treatments?
Red light therapy has less established evidence than standard treatments for painful diabetic neuropathy.
The American Academy of Neurology recommends considering medications from the tricyclic antidepressant, serotonin-norepinephrine reuptake inhibitor, gabapentinoid and sodium-channel blocker classes. The guideline also supports discussing exercise, cognitive behavioral therapy, mindfulness and certain topical treatments according to the patient's circumstances.
An older AAN guideline, based on evidence available through 2008, concluded that low-intensity laser treatment probably should not be used for painful diabetic neuropathy because a high-quality trial had not shown a pain benefit. Newer reviews are more favorable, but they still identify inconsistent protocols and limited follow-up. Red light therapy therefore remains a supplementary option rather than a standard first-line treatment.
Is a Home Red-Light Device Worth Trying?
A home device may be worth considering only after the neuropathy has been properly evaluated. It may be reasonable when:
- The goal is additional pain relief rather than nerve regeneration.
- The device states its wavelength and treatment protocol clearly.
- The manufacturer gives a defined neuropathy indication rather than making broad pain claims.
- A healthcare professional agrees that it is suitable.
- Treatment will not delay diabetes management, medication review, physical therapy or assessment of worsening symptoms.
Be cautious with products that promise to "cure neuropathy," permanently restore sensation or regenerate nerves without clinical evidence. Home photobiomodulation devices vary widely, and a device marketed for skin care is not automatically suitable for neuropathy.
Safety and When to Seek Medical Care
Short-term red-light therapy appears generally well tolerated when used as directed. Eye protection and the manufacturer's instructions still matter. Misuse can cause eye or skin problems, and the long-term safety of many consumer devices has not been fully established.
Do not use red light therapy to self-treat new or unexplained numbness, weakness, balance problems or worsening pain without medical evaluation. Mayo Clinic recommends assessment for tingling, weakness or pain in the hands or feet because early diagnosis may help prevent further nerve damage.
Sudden numbness on one side of the body, especially with weakness, confusion, trouble speaking, dizziness or a severe headache, requires emergency medical attention.
Bottom Line
Red light laser therapy may be reasonable as an additional treatment for neuropathic pain after the cause of the neuropathy has been assessed. The strongest evidence is in diabetic peripheral neuropathy, but it remains limited. There is not enough evidence to use it as a treatment for nerve regeneration, established numbness or the underlying cause of neuropathy.
If you are considering a device, discuss its exact wavelength, protocol and medical indication with a clinician. Avoid products that make broad cure claims without clinical evidence.